Medical

Battle-tested, this real-world data confirms the clinical efficacy of Azulfidine!

Latest real-world data published, providing real evidence of the effectiveness of Azulfidine in patients with COVID-19

Apparatus

New Findings Confirm: Excellent Data On This Bipotent Antibody Drug Against Ovarian Cancer!

The results of a new study show that Ubamatamab, a bispecific antibody drug, has shown excellent results and a good safety profile in patients with ovarian cancer.